Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Accumulated Expenses (2016 - 2025)

Surgery Partners (SGRY) has disclosed Accumulated Expenses for 12 consecutive years, with $64.9 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 7.45% to $64.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.9 million through Dec 2025, up 7.45% year-over-year, with the annual reading at $64.9 million for FY2025, 7.45% up from the prior year.
  • Accumulated Expenses hit $64.9 million in Q4 2025 for Surgery Partners, down from $69.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $83.8 million in Q1 2022 to a low of $59.3 million in Q2 2025.
  • Historically, Accumulated Expenses has averaged $70.3 million across 5 years, with a median of $68.8 million in 2022.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 62.95% in 2021 and later fell 23.27% in 2023.
  • Year by year, Accumulated Expenses stood at $77.1 million in 2021, then fell by 10.64% to $68.9 million in 2022, then rose by 7.11% to $73.8 million in 2023, then fell by 18.16% to $60.4 million in 2024, then rose by 7.45% to $64.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for SGRY at $64.9 million in Q4 2025, $69.9 million in Q3 2025, and $59.3 million in Q2 2025.